Skip to content

Pilot study in gait perturbations in patients with chronic obstructive pulmonary disease

Pilot study in gait perturbations in patients with chronic obstructive pulmonary disease - Gait perturbations in COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45605
Enrollment
24
Registered
2017-08-01
Start date
2018-10-08
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic bronchitis chronic obstructive pulmonary disease (COPD) emphysema

Interventions

COPD
Dynamic balance
Gait
Perturbations

Sponsors

Ciro
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Older healthy adults: - Healthy subjects - Aged between 50-80 years old - No known musculoskeletal disease, condition or injury that could negatively affect walking or balance ability - No history of balance problems, dizziness or walking difficulties - Must be able to walk at comfortable speed for 30 minutes without stopping - Informed consent given;Patients with COPD - Main diagnosis is COPD, diagnosed at CIRO (FEV1/FVC

Exclusion criteria

Exclusion criteria: - musculoskeletal disease, condition or injury - subject is unable to walk without walking aids - subject is unable to perform the 6-minute walk test without a stop - subject with open wounds - subject with balance problems, dizziness or walking difficulties (for healthy older adults)

Design outcomes

Primary

MeasureTime frame
The main study parameter is the reactive adaptation potential measured during the locomotor plasticity assessment protocol with the Gait Real-time Analysis Interactive Lab. This will be calculated as the magnitude of change in the margin of stability at touchdown of the first step after the perturbation before and after repetition of the perturbation.

Secondary

MeasureTime frame
Walking speed, step width, step length, cadence at touchdown of the first and following recovery steps after each perturbation.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)